Cytotoxicity and chromosome aberrations in vitro: Experience in industry and the case for an upper limit on toxicity in the aberration assay

Environmental and Molecular Mutagenesis

Volumn 35, Issue 3, 2000, Pages 191-201

  Galloway, Sheila M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chinese hamster ovary cells; Chromosome aberrations; Cytotoxicity; Primary human lymphocytes

Indexed keywords

CLASTOGEN; DNA TOPOISOMERASE INHIBITOR; FOLIC ACID ANTAGONIST; NUCLEOSIDE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL CELL; CHROMOSOME ABERRATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DNA DAMAGE; DOSE RESPONSE; GENOTOXICITY; HAMSTER; HEALTH SURVEY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MITOSIS INDEX; NONHUMAN; TOXICITY TESTING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0034032414     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(2000)35:3<191::AID-EM6>3.0.CO;2-4     Document Type: Conference Paper

References (28)

1. Armstrong MJ, Bean CL, Galloway SM. 1992. A quantitative assessment of the cytotoxicity associated with chromosomal aberration detection in Chinese hamster ovary cells. Mutat Res 265:45-60.
2. Wafl/Cipl expression. Oncogene 117:1601-1703.
3. Bradley MO, Taylor VI, Armstrong MJ, Galloway SM. 1987. Relationships among cytotoxicity, lysosomal breakdown, chromosome aberrations, and DNA double strand breaks. Mutat Res 189:69-79.
4. Cerny M, Baudysova M, Holeckove E. 1966. Adaptation of mammalian cells to cold. II. Cold-induced endoreduplication and polyploidy. Exp Cell Res 40:673-677.
5. Elia MC, Storer RD, McKelvey TW, Kraynak AR, Barnum JE, Harmon LS, DeLuca JG, Nichols WW. 1994. Rapid DNA degradation in primary rat hepatocytes treated with diverse cytotoxic chemicals: analysis by pulsed field gel electrophoresis and implications for alkaline elution assays. Environ Mol Mutagen 24:181-191.
6. Galloway SM, Deasy DA, Bean CL, Kraynak, AR, Armstrong MJ, Bradley MO. 1987. Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity. Mutat Res 189:15-25.
7. Galloway SM, Aardema MJ, Ishidate Jr M, Ivett JL, Kirkland DJ, Morita T, Mosesso P, Sofuni T. 1994. Report from working group on in vitro tests for chromosomal aberrations. Mutat Res 312:241-261.
8. Galloway SM, Miller JE, Armstrong MJ, Bean CL, Skopek TR, Nichols WW. 1998. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutation Res 400:169-186
9. Galloway S, Greenwood S, Hill R, Sun J, Armstrong M, Johnson T, Gara J. 2000. A simple method for more accurate calculation of cell growth for the in vitro chromosome aberration assay. Environ Mol Mutagen (in press).
10. Hampel KE, Levan A. 1964. Breakage in human chromosomes induced by low temperatures. Hereditas 51:315-343.
11. Hilliard CA, Armstrong MJ, Bradt CI, Hill RB, Greenwood SK, Galloway SM. 1998. Chromosome aberrations in vitro related to cytotoxicity of non-mutagenic chemicals and metabolic poisons. Environ Mol Mutagen 31:316-326.
12. Hu T, Miller CM, Ridder GM, Aardema MJ. 1999. Characterization of p53 in Chinese hamster cell lines CHO-KI, CHO-WBL and CHO: implications for genotoxidty testing. Mutation Res 426: 51-62.
13. Huang Y, Chang, C, Trosko, JE. 1983. Aphidicolin-induced endoreduplication in Chinese hamster cells. Cancer Res 43:1361-1364.
14. International Conference on Harmonization. 1996. Guidance on genotoxicity. guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. Federal Register 61:18198.
15. International Conference on Harmonization. 1997. A standard battery for genotoxicity testing of pharmaceuticals. Federal Register 62:62472-5.
16. Ishidate M, Jr, Sofuni T, Yoshikawa K, Hayashi M, Nohmi T, Sawada M, Matsuoka A. 1984. Primary mutagenicity screening of food additives currently used in Japan. Fd Chem Toxic 22:623-636.
17. Kirkland DJ. 1992. Chromosomal aberration tests in vitro: problems with protocol design and interpretation of results. Mutagenesis 7:99-106.
18. Kirkland DJ. 1994. Report of the International Workshop on Standardisation of Genotoxicity Test Procedures; Report of the in vitro subgroup. Mutat Res 312:211-215.
19. Kirkland DJ, Müller L. 2000. Interpretation of the biological relevance of genotoxicity test results: The importance of thresholds. Mutat Res 464:137-147.
20. 2 arrest. Mutation Res 119:407-413.
21. Mitchell I deG, Lambert TR, Burden M, Sunderland J, Porter JL, Carlton JB. 1995. Is polyploidy an important genotoxic lesion? Mutagenesis 10:79-83.
22. Müller L, Kasper P. 2000. Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutation Res 464:19-34.
23. Müller L, Kikuchi, Y, Probst, G., Schechtman L, Shimada H, Sofuni T, Tweats, D. 1999. ICH-harmonized guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat Res 436:195-225.
24. OECD. 1997. Guideline for the Testing of Chemicals. #473. In Vitro Mammalian Chromosome Aberration Test.
25. Scott, D, Galloway SM, Marshall RR, Ishidate M, Jr. Brusick D, Ashby J, Myhr BC. 1991. Genotoxicity under extreme culture conditions. A report from ICPEMC task group 9. Mutat Res 257:147-204
26. Sepp-Lorenzino L, Rosen N. 1998. A farnesyl-protein transferase inhibitor induced p21 expression and G1 block in p53 wild-type tumor cells. J Biol Chem 273:20243-20251.
27. Storer RD, McKelvey TW, Kraynak AR, Elia MC, Barnum JE, Harmon LS, Nichols WW, DeLuca JG. 1996. Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: Improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds. Mutat Res 368:59-101.
28. Vock EH, Lutz, WK, Hormes P, Hoffmann HD, Vamvakas S. 1998. Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide. Triton X-100 and γ-irradiation. Mutat Res 413:8.3-94.